Lymphoma News and Research

RSS

Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.

Detection of gene fusions in prostate cancer

Researchers at the University of Michigan Comprehensive Cancer Center have discovered how genes turn on the switch that leads to prostate cancer.

3 Aug 2007

Genta and Emisphere Technologies file investigational new drug exemption

Genta Inc. and Emisphere Technologies, Inc. have jointly announced the submission of an Investigational New Drug Exemption (IND) to the Endocrinologic and Metabolic Drugs Division of the U.S. Food and Drug Administration (FDA) for a new drug known as G4544.

2 Aug 2007

New target for Hodgkin lymphoma

Dana-Farber Cancer Institute scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells.

1 Aug 2007

Antibody targets nanotubes to tumors

Researchers at Memorial Sloan-Kettering Cancer Center have created biocompatible single-walled carbon nanotubes that can target lymphomas and deliver both imaging and therapeutic molecules to these tumors.

23 Jul 2007

Study looks at cancer incidence among recipients of blood from donors

Individuals who receive blood transfusions from donors with undiagnosed cancers are at no higher risk of developing malignant disease than people who receive blood from donors without cancer, according to the results of a retrospective study published in The Lancet last month.

23 Jul 2007

Blood transfusions not likely to spread cancer

23 Jul 2007

Prevention and treatment of vitamin D deficiency

Boston, MA:In a review article to appear in the July 19th issue of the New England Journal of Medicine, Dr. Michael Holick, an internationally recognized expert in vitamin D, provides an overview of his pioneering work that expounds on the important role vitamin D plays in a wide variety of chronic health conditions, as well as suggesting strategies for the prevention and treatment of vitamin D deficiency.

19 Jul 2007

Cutaneous T-cell lymphoma becomes more common in U.S.

The cancer known as cutaneous T-cell lymphoma became substantially more common in the United States between 1973 and 2002, according to a report in the July issue of Archives of Dermatology.

17 Jul 2007

Wilmot Cancer Center studies new chemo pill for lymphoma

Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.

12 Jul 2007

Etravirine reduces HIV viral loads when taken with Prezista

The experimental antiretroviral drug etravirine, made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals, greatly reduces HIV viral loads in people with a history of drug resistance when taken in combination with Tibotec's antiretroviral Prezista, according to two studies published Saturday in the journal The Lancet.

10 Jul 2007

Cancer risk in HIV, transplant patients

HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.

8 Jul 2007

Are we looking at cancer vaccine trials the wrong way?

Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment.

4 Jul 2007

Rethinking therapeutic cancer vaccine trials

3 Jul 2007

New type of drug shows promise for chronic lymphocytic leukemia

A new type of engineered drug candidate has shown promise in treating chronic lymphocytic leukemia in both test tube and early animal tests, a new study shows.

29 Jun 2007

Biovest announces interim blinded data of fast-tracked pivotal phase 3 clinical trial of BiovaxID

Biovest International announced on June 27, 2007 blinded interim data from the start of its fast-tracked pivotal Phase 3 clinical trial of BiovaxID for Non-Hodgkin's lymphoma (NHL) from September 2000 through June 2006.

29 Jun 2007

Umbilical cord blood may safely preserve insulin production in children newly diagnosed with type 1 diabetes

University of Florida researchers sought to determine whether it is feasible to use a patient's own cord blood stem cells to neutralize the body's autoimmune attack on the pancreas and help restore the organ's ability to make insulin, which regulates how the body uses sugar and other nutrients for energy.

27 Jun 2007

Aptamer-targeted nanoparticles collect and detect cancer cells

Using magnetic and fluorescent nanoparticles capable of binding tightly to molecules found only on the surface of cancer cells, a team of investigators at the University of Florida has developed a method for collecting and detecting multiple cancer cells from biological samples.

14 Jun 2007